GPR56

From WikiMD's WELLNESSPEDIA

GPR56
GPR56


GPR56 is a gene that encodes the G protein-coupled receptor 56 in humans. This receptor is part of the adhesion G protein-coupled receptor (GPCR) family, which is characterized by an extended extracellular region with various protein domains. GPR56 plays a crucial role in several biological processes, including brain development, cancer progression, and cell adhesion.

Function[edit]

GPR56 is involved in the regulation of various cellular functions through its interaction with G proteins. In the brain, it is essential for the development of the cerebral cortex, influencing the proliferation and migration of neural progenitor cells. Mutations in the GPR56 gene have been associated with bilateral frontoparietal polymicrogyria (BFPP), a rare neurological disorder characterized by abnormal brain development and epilepsy.

In addition to its role in the brain, GPR56 has been implicated in the regulation of tumor progression and metastasis in several types of cancer. It can act as either a tumor suppressor or promoter, depending on the cellular context and the type of cancer. The receptor's interaction with its ligands and the subsequent activation of downstream signaling pathways are critical for its function in tumor biology.

Clinical Significance[edit]

The study of GPR56 has significant clinical implications, particularly in the fields of neurology and oncology. Understanding the molecular mechanisms underlying GPR56's functions could lead to the development of novel therapeutic strategies for diseases associated with this receptor, such as BFPP and certain cancers. For instance, targeting GPR56 or its signaling pathways could offer new approaches for the treatment of tumors with altered GPR56 expression.

Research[edit]

Research on GPR56 is ongoing, with studies focusing on elucidating its structure, ligand interactions, and signaling mechanisms. The identification of specific ligands and the development of small molecule modulators are areas of active investigation, which could pave the way for GPR56-targeted therapies.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.